Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Bloomfield

Showing results (211-220 of 289) with videos related to

Pageof 29
Sort By:
Blood|January 11, 2000
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129J L Slack, C L Willman, J W Andersen, et al.
Haematology and Blood Transfusion|January 1, 1985
Chromosome abnormalities in malignant lymphoma: biologic and clinical correlationsC D Bloomfield, D C Arthur, E G Levine, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogeneticsK Virtaneva, F A Wright, S M Tanner, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group BD B Duggan, M T Santarelli, K Zamkoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251E J Lee, G R Petroni, C A Schiffer, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Blood|March 1, 1985
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodiesR E Sobol, I Royston, T W LeBien, et al.
Leukemia|April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometryM R Baer, C C Stewart, D Lawrence, et al.
Cancer|April 1, 1982
Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804S J Ginsberg, S T Crooke, C D Bloomfield, et al.
Pageof 29

Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
Blood|January 11, 2000
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129J L Slack, C L Willman, J W Andersen, et al.
Haematology and Blood Transfusion|January 1, 1985
Chromosome abnormalities in malignant lymphoma: biologic and clinical correlationsC D Bloomfield, D C Arthur, E G Levine, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogeneticsK Virtaneva, F A Wright, S M Tanner, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group BD B Duggan, M T Santarelli, K Zamkoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251E J Lee, G R Petroni, C A Schiffer, et al.
Cancer|March 1, 1993
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group BR Mir, J Anderson, J Strauchen, et al.
Blood|March 1, 1985
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodiesR E Sobol, I Royston, T W LeBien, et al.
Leukemia|April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometryM R Baer, C C Stewart, D Lawrence, et al.
Cancer|April 1, 1982
Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804S J Ginsberg, S T Crooke, C D Bloomfield, et al.
Pageof 29